Lowers excessive prolactin for selected endocrine indications.
Profile scope: Cabergoline. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Digestive upset, dizziness, tiredness, or altered sensation may occur.
Serious risks and warning signs
Heart-valve and tissue-scarring history require screening. New breathlessness, swelling, chest discomfort, reduced urination, or vision changes need prompt advice. Compulsive behaviors have been reported, with causation not established in the source.
A question for your healthcare team
What heart checks do I need, and which changes in breathing, vision, or behavior should my family report?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.